Vol. 6, Issue 2, Part C (2024)

Abnormal cholesterol levels are crucial in assessing cardiovascular risk. Cardiovascular diseases (CADs) account for a significant global health threat, with the World Health Organization (WHO) projecting that over 23 million people will die from CADs by 2030. Low-density lipoprotein (LDL) and high-density lipoprotein (HDL) levels play a key role in atherosclerosis and overall cardiovascular health. The build up of plaque in the arterial walls impairs blood flow, leading to atherosclerosis. High cholesterol is also associated with myocardial infarction, coronary artery disease, and stroke. Risk factors for CADs include high blood sugar, obesity, smoking, and alcohol consumption, though some factors, such as family history, cannot be altered. Current evidence suggests that dyslipidemia is a strong predictor of cardiovascular disease. Statin therapy targeting LDL can reduce the incidence of major CADs. Individuals aged 50-70 are at higher risk for CADs, although age alone is not a definitive factor. Utilizing medical technology and diagnostic tools can help identify high-risk patients and prevent adverse outcomes effectively. Understanding the relationship between cholesterol levels and cardiovascular risk is essential for improving prevention strategies.